Form 1-K Issuer Information | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1-K | OMB APPROVAL |
| OMB Number: 3235-0720 Estimated average burden hours per response: 600.0 |
1-K: Filer Information
Issuer CIK | 0001702206 |
Issuer CCC | XXXXXXXX |
Is filer a shell company? | ![]() ![]() |
Is the electronic copy of an official filing submitted in paper format? | ![]() |
File Number | |
Is this filing by a successor company pursuant to Rule 257(b)(5) resulting from a merger or other business combination? | ![]() ![]() |
Successor File Number |
Is this a LIVE or TEST Filing? | ![]() ![]() |
Would you like a Return Copy? | ![]() |
Period | 12-31-2021 |
Name | |
Phone | |
E-Mail Address |
Notify via Filing Website only? | ![]() |
1-K: Tab 1 Notification
This Form 1-K is to provide an | ![]() ![]() |
Fiscal Year End | 12-31-2021 |
Exact name of issuer as specified in the issuer's charter | NowRx |
CIK | 0001702206 |
Jurisdiction of Incorporation / Organization | DELAWARE |
I.R.S. Employer Identification Number | 27-4286597 |
Address 1 | 2224 OLD MIDDLEFIELD WAY |
Address 2 | |
City | MOUNTAIN VIEW |
State/Country | CALIFORNIA |
Mailing Zip/ Postal Code | 94043 |
Phone | 650-386-5761 |
Title of each class of securities issued pursuant to Regulation A | Series A Preferred Stock; Series B Preferred Stock; Series C Preferred Stock |